A Novel Prognostic Ferroptosis-Related Long Noncoding RNA Signature in Clear Cell Renal Cell Carcinoma

Figure 6

(a) The distinct distribution pattern between two different groups of ccRCC. (b) The survival status and time of ccRCC patients. (c) The relative expression standards of each ccRCC patient. (d) The AUC of the FRLRS signature and traditional clinical variables. (e) The DCA of the risk score and other clinical variables. (f) The c-index of the risk score and other clinical variables.

(a)

(b)

(c)

(d)

(e)

(f)